Found 348 Enz. Inhib. hit(s) with Target = 'Fusion glycoprotein F0' TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.690nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
3D Structure (crystal)TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 4.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 6.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 71nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 183nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 641nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.07E+3nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of RSV Long fusion protein L138F mutant assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after ...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataIC50: 2.56E+3nMAssay Description:Inhibition of RSV Long fusion protein L138F mutant assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after ...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 1.00E+5nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 221nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 140nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 5nMAssay Description:Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillographyMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 12nMAssay Description:Inhibition of DGAT1 in rat adipose tissue assessed as reduction in triacylglycerol synthesisMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of DGAT1 in human HuTu80 cellsMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 5.42E+3nMAssay Description:Inhibition of DGAT1 in human liver microsomesMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 4nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 12nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 4.30nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 2.41E+3nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 3nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 17nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 54nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 78nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 180nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 290nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 53nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 93nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 100nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
